APA Citatie

Hanker, A. B., Brewer, M. R., Sheehan, J. H., Koch, J. P., Sliwoski, G. R., Nagy, R., . . . Arteaga, C. L. (2017). An acquired HER2 T798I gatekeeper mutation induces resistance to neratinib in a patient with HER2 mutant-driven breast cancer. Cancer Discov.

Chicago Style citaat

Hanker, Ariella B., et al. "An Acquired HER2 T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient With HER2 Mutant-driven Breast Cancer." Cancer Discov 2017.

MLA citatie

Hanker, Ariella B., et al. "An Acquired HER2 T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient With HER2 Mutant-driven Breast Cancer." Cancer Discov 2017.